Cooper Cooper is a global medical device company. The firm is scheduled to report its first-quarter earnings on Feb. 27. Forward Annual Dividend Yield: 0.1% Rated "B+ (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin was about the same as one year ago. Cooper has weak liquidity. Its Quick Ratio is 0.82, which demonstrates a lack of ability to meet its short-term cash needs. In the fourth quarter, stockholder's net worth increased 16.24% from the previous year. TheStreet Ratings' price target is $92.40. Shares closed Thursday at $70.87.